BBIO vs UBER · rev $221.9M vs P/E 18, rev $52.02B
BridgeBio Pharma Inc (BBIO) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
BBIO currently screens at market cap $13.24B. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the BBIO and UBER stock pages for the full models.
Not investment advice.